TACR2 Polyclonal antibody

• Home
• Products
• Primary Antibodies
• TACR2 Polyclonal antibody (25270-1-AP)

TACR2 Polyclonal Antibody for WB, FC (Intra), ELISA

Cat No. 25270-1-AP Copied!

Publications (2)

Download datasheet

Host / Isotype

Rabbit / IgG

Reactivity

human and More (1)

Applications

WB, IHC, FC (Intra), ELISA

Synonyms

Neurokinin A receptor, NK 2 receptor, NK 2R, NK-2 receptor, NK2R

• 

  WB analysis of HeLa using 25270-1-AP

  HeLa cells were subjected to SDS PAGE followed by western blot with 25270-1-AP (TACR2 Antibody) at dilution of 1:600 incubated at room temperature for 1.5 hours.

  This validation data has been generated in-house and reviewed by Proteintech scientists. Find out more on our antibody validation policy
• 

  WB analysis of PC-3 using 25270-1-AP

  PC-3 cells were subjected to SDS PAGE followed by western blot with 25270-1-AP (TACR2 Antibody) at dilution of 1:600 incubated at room temperature for 1.5 hours.

  This validation data has been generated in-house and reviewed by Proteintech scientists. Find out more on our antibody validation policy
• 

  FC experiment of HeLa using 25270-1-AP

  1x10^6 HeLa cells were intracellularly stained with 0.25 ug TACR2 Polyclonal antibody (25270-1-AP) and CoraLite®488-Conjugated Goat Anti-Rabbit IgG(H+L) (SA00013-2)(red), or 0.25 ug Isotype Control (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer.

  This validation data has been generated in-house and reviewed by Proteintech scientists. Find out more on our antibody validation policy

Able AI

What's the best dilution for TACR2 in ?

Chat with Able

---

Tested Applications

• Positive WB detected in: HeLa cells, PC-3 cells
• Positive FC (Intra) detected in: HeLa cells

Recommended dilution

• Western Blot (WB): WB : 1:500-1:1000
• Flow Cytometry (FC) (INTRA): FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, Check data in validation data gallery.

Product Information

25270-1-AP targets TACR2 in WB, IHC, FC (Intra), ELISA applications and shows reactivity with human samples.

• Tested Reactivity: human
• Cited Reactivity: human, rat
• Host / Isotype: Rabbit / IgG
• Class: Polyclonal
• Type: Antibody
• Immunogen:

  Peptide

• Full Name: tachykinin receptor 2
• Calculated Molecular Weight: 44 kDa
• Observed Molecular Weight: 44 kDa
• GenBank Accession Number: NM_001057
• Gene Symbol: TACR2
• Gene ID (NCBI): 6865
• RRID: AB_2879998
• Conjugate: Unconjugated
• Form: Liquid
• Purification Method: Antigen affinity purification
• UNIPROT ID: P21452
• Storage Buffer: PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
• Storage Conditions: Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20^oC storage. 20ul sizes contain 0.1% BSA.

Background Information

The tachykinins represent a family of peptide neurotransmitters including substance P, neurokinin A and neurokinin B, which act through the stimulation of tachykinin NK1, NK2 or NK3 receptors. NK2, also known as TACR2 (tachykinin receptor 2), is a receptor for the tachykinin neurokinin A (neuropeptide substance K). It is associated with G proteins that activate a phosphatidylinositol-calcium second messenger system.

Publications

What published studies show

The TACR2 Polyclonal antibody (Cat# 25270-1-AP) has 2 citations. These appear in Cancer Cell International and Molecular Medicine Reports. The research fields include prostate cancer, specifically examining TACR2's role in the immune microenvironment and its inhibition of migration/proliferation via Wnt/β-catenin signaling, and spinal fusion, investigating substance P and neurokinin receptor occurrence during early-phase fusion.

Automatically generated from the 2 publication citations by Able AI.

• Human
• Mouse
• Rat
• Monkey
• Pig

Species	Application	Title
human	WB	Cancer Cell Int; TACR2 is associated with the immune microenvironment and inhibits migration and proliferation via the Wnt/β-catenin signaling pathway in prostate cancer.; Authors - Wang Jianfeng
rat	IHC	Mol Med Rep; Occurrence of substance P and neurokinin receptors during the early phase of spinal fusion.; Authors - Suiyi Wu